Stocks
Canopy Growth CorporationCGC
NASDAQHealthcareDrug Manufacturers - Specialty & Generic$0.93-1.92%
Price as of · delayed, not real-time
A Canadian-based cannabis company focused on producing and selling medical and recreational cannabis products globally. Investors track it as one of the largest publicly traded cannabis producers, though it has faced challenges with profitability and market saturation.
Market Cap: $524.8M52W Range: $0.84-$2.38
Congressional Interest in Canopy Growth Corporation (CGC)
2 members of Congress have disclosed 5 trades in Canopy Growth Corporation (CGC), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
5
Unique Politicians
2
Buys
4
Sells
1
Who in Congress Is Trading CGC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-02-12 | John A. Yarmuth | buy | $1K-$15K |
| 2020-11-05 | John A. Yarmuth | buy | $1K-$15K |
| 2020-03-10 | John A. Yarmuth | sell | $1K-$15K |
| 2020-03-10 | John A. Yarmuth | buy | $1K-$15K |
| 2018-10-23 | Brenda Lulenar Lawrence | buy | $1K-$15K |